Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs Champions Oncology, Inc. (CSBR)

Cognition Therapeutics, Inc. and Champions Oncology, Inc. are both Biotechnology companies. Cognition Therapeutics, Inc. and Champions Oncology, Inc. are of similar size ($69.7M and $66.7M). Cognition Therapeutics, Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (0.00% vs −626.2%). Across the 13 metrics below, Cognition Therapeutics, Inc. leads on 7 and Champions Oncology, Inc. on 6.

Valuation

Metric CGTX CSBR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.08 9.71
P/B 2.00 14.65 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 196.33 0.64
EV/Sales n/m 1.01 9.21
Earnings yield (23.29%) (1.70%) (33.15%)
Free cash flow yield (26.75%) (9.36%) (25.50%)

Profitability

Metric CGTX CSBR Biotechnology median
Gross margin 0.00% 49.82% 65.16%
Operating margin 0.00% (1.68%) 0.00%
Net margin 0.00% (1.87%) 0.00%
Free cash flow margin 0.00% (10.08%) 0.00%
Return on equity (83.76%) (28.38%) (56.36%)
Return on assets (57.33%) (3.56%) (48.04%)
Return on invested capital 0.00% (626.23%) 0.00%

Growth

Metric CGTX CSBR Biotechnology median
Revenue growth (TTM) — 6.65% 6.02%
EPS growth (last fiscal year) 62.79% (124.24%) 30.26%
Revenue growth, 5-year CAGR — 7.68% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX CSBR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.03 1.03 4.72
Net debt to EBITDA 0.78 (20.56) 0.96

Dividend

Metric CGTX CSBR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGTX CSBR Biotechnology median
Market cap 69.67m 66.67m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack